Developing a variety of highly specialized, self-expanding stents
in a range of shapes, lengths and diameters. Each stent design is
based on the proprietary, patented core technology, adapted to
the shape of the occluded passageway of the body that is to be
treated.
Employees: 15
Overview
ALLIUM LTD. is an Israeli R&D subsidiary of a privately owned
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
company Allium Inc., incorporated in Delaware.
ALLIUM is a medical device company with a mission of offering the
medical community the next generation of stents and stent-like
devices based on it's proprietary technological platform,
enabling physicians to offer more effective stent solutions for
enhancing patients' quality of life.
ALLIUM has invented a multi-patented technological platform for
developing site-specific stent solutions.
Since its inception ALLIUM has focused primarily on researching,
developing, and testing a variety of stents and stent delivery
systems with applications in the urinary, gastro-intestinal and
respiratory tract for use in malignant and benign obstructions.
ALLIUM has already proved its proprietary technology by
developing site-specific stents with applications in the urinary
and gastrointestinal tract, which have been subjected to rigorous
laboratory and animal tests and clinical feasibility studies with
successful outcomes.
The self-expanding ALLIUM stents are made of superelastic
material and are covered with a layer of polymeric material to
prevent tissue ingrowth and reduce encrustation. Despite their
excellent radial force and high flexibility, they are crush-proof
and have a soft touch for maximum patient comfort.
